このアイテムのアクセス数: 29

このアイテムのファイル:
ファイル 記述 サイズフォーマット 
s12879-024-09894-w.pdf2.42 MBAdobe PDF見る/開く
完全メタデータレコード
DCフィールド言語
dc.contributor.authorLiu, Shiqien
dc.contributor.authorAnzai, Asamien
dc.contributor.authorNishiura, Hiroshien
dc.contributor.alternative安齋, 麻美ja
dc.contributor.alternative西浦, 博ja
dc.date.accessioned2024-11-21T02:07:04Z-
dc.date.available2024-11-21T02:07:04Z-
dc.date.issued2024-09-12-
dc.identifier.urihttp://hdl.handle.net/2433/290474-
dc.description.abstractBackground: Japan implemented strict border control measures and all incoming passengers were subject to entry screening with reverse transcription-polymerase chain reaction or antigen testing. From late 2020, exit screening within 72 h of departure to Japan also became mandatory. In this study, we evaluated the effectiveness of the exit screening policy in Japan by analyzing airport screening data from October 2020 to April 2022. Methods: In addition to assessing entry screening data over time of passengers from the United Kingdom, we examined the prevalence of coronavirus disease 2019 (COVID-19) in the United Kingdom based on the Office of National Statistics infection survey. We constructed a statistical model that described entry screening positivity over time using Office of National Statistics prevalence data as the explanatory variable. Ideally, the time-dependent patterns of entry screening and Office of National Statistics prevalence data should resemble each other; however, we found that, sometimes, they were different and regarded the difference to statistically partly reflect the effectiveness of exit screening. Results: The average proportion positive in one month before mandatory exit screening was implemented among Japanese passengers was 0.67% (95% confidence interval [CI]: 0.45, 0.98), whereas the proportion positive decreased to 0.49% (95% CI: 0.21, 1.15) in the first month of exit screening. Adjusting for time-dependent prevalence at the origin, we concluded that exit screening contributed to reducing passenger positivity by 59.3% (95% CI: 19.6, 81.3). The overall positivity values among passengers during the Delta and Omicron variant periods were 3.46 times and 1.46 times that during the pre-Delta variant period, respectively. Conclusions: We used a simplistic statistical model and empirical data from passengers arriving in Japan from the United Kingdom to support that exit screening helped to reduce the proportion positive by 59%. Although the proportion positive later increased considerably and precluded preventing the introduction of imported cases, submitting a certificate for a negative test result contributed to reducing the positivity among travelers.en
dc.language.isoeng-
dc.publisherSpringer Natureen
dc.publisherBMCen
dc.rights© The Author(s) 2024.en
dc.rightsThis article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder.en
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/4.0/-
dc.subjectSevere acute respiratory syndrome coronavirus 2en
dc.subjectBorder controlen
dc.subjectQuarantineen
dc.subjectTravelen
dc.subjectStatistical estimationen
dc.subjectEffectivenessen
dc.titleAssessing exit screening of SARS-CoV-2 in Japan: an analysis of the airport screening data of passengers from the United Kingdom, 2020–2022en
dc.typejournal article-
dc.type.niitypeJournal Article-
dc.identifier.jtitleBMC Infectious Diseasesen
dc.identifier.volume24-
dc.relation.doi10.1186/s12879-024-09894-w-
dc.textversionpublisher-
dc.identifier.artnum962-
dc.identifier.pmid39267012-
dcterms.accessRightsopen access-
dc.identifier.eissn1471-2334-
出現コレクション:学術雑誌掲載論文等

アイテムの簡略レコードを表示する

Export to RefWorks


出力フォーマット 


このアイテムは次のライセンスが設定されています: クリエイティブ・コモンズ・ライセンス Creative Commons